6,672 research outputs found
Optimal Microlensing Observations
One of the major limitations of microlensing observations toward the Large
Magellanic Cloud (LMC) is the low rate of event detection. What can be done to
improve this rate? Is it better to invest telescope time in more frequent
observations of the inner high surface-brightness fields, or in covering new,
less populated outer fields? How would a factor 2 improvement in CCD
sensitivity affect the detection efficiency? Would a series of major (factor
2--4) upgrades in telescope aperture, seeing, sky brightness, camera size, and
detector efficiency increase the event rate by a huge factor, or only
marginally? I develop a simplified framework to address these questions. With
observational resources fixed at the level of the MACHO and EROS experiments,
the biggest improvement (factor ~2) would come by reducing the time spent on
the inner ~25 deg^2 and applying it to the outer ~100 deg^2. By combining this
change with the characteristics of a good medium-size telescope (2.5 m mirror,
1" point spread function, thinned CCD chips, 1 deg^2 camera, and dark sky), it
should be possible to increase the detection of LMC events to more than 100 per
year (assuming current estimates of the optical depth apply to the entire LMC).Comment: Submitted to ApJ, 13 pages plus 3 figure
Signal perception and belief updating
This paper introduces a theory of signal perception to study how people update their beliefs. By allowing perceived signals to deviate from actual signals, we identify the probability that people miss or misread signals, giving indices of conservatism and confirmatory bias. In an experiment, we elicited perceived signals from choices and obtained a structural estimation of the indices. The subjects were conservative and acted as if they missed 65% of the signals they received. Also they exhibited confirmatory bias by misreading 17% of the signals contradicting their prior beliefs
AGAPE, an experiment to detect MACHO's in the direction of the Andromeda galaxy
The status of the Agape experiment to detect Machos in the direction of the
andromeda galaxy is presented.Comment: 4 pages, 1 figure in a separate compressed, tarred, uuencoded uufile.
In case ofproblem contact [email protected]
AgapeZ1: a Large Amplification Microlensing Event or an Odd Variable Star Towards the Inner Bulge of M31
AgapeZ1 is the brightest and the shortest duration microlensing candidate
event found in the Agape data. It occured only 42" from the center of M31. Our
photometry shows that the half intensity duration of the event6 is 4.8 days and
at maximum brightness we measure a stellar magnitude of R=18.0 with B-R=0.80
mag color. A search on HST archives produced a single resolved star within the
projected event position error box. Its magnitude is R=22.Comment: 4 pages with 5 figure
Cost-effectiveness analysis of ceftazidime/avibactam compared to imipenem as empirical treatment for complicated urinary tract infections
Ceftazidime/avibactam (CAZ-AVI) is a novel, fixed-dose combination antibiotic that has been approved in Europe and the United States for patients with complicated urinary tract infections (cUTIs) based on results of a Phase III, randomized, comparative study (RECAPTURE study). The present analysis evaluated cost-effectiveness of CAZ-AVI as an empirical treatment for hospitalized patients with cUTIs from the Italian publicly funded healthcare (third-party payer) perspective. A sequential, patient-level simulation model was developed that followed the clinical course of cUTI and generated 5000 pairs of identical patients (CAZ-AVI or imipenem as empirical treatment). The model included additional impact of resistant pathogens; patients who did not respond to empirical treatment were switched to second-line treatment of colistin+high dose carbapenem in both groups. The time horizon of the model was five years, with an annual discount rate of 3% applied to both costs and quality-adjusted life-years (QALYs). The analysis demonstrated that an intervention sequence (CAZ-AVI followed by colistin+high dose carbapenem) compared with a comparator sequence (imipenem followed by colistin+high dose carbapenem) was associated with a net incremental cost of €1015 per patient but provided better health outcomes in terms of clinical cure (97.65% vs. 91.08%; ∆ = 6.57%), shorter hospital stays (10.65 vs. 12.55 days; ∆ = 1.90 days), and QALYs gained per patient (4.190 vs. 4.063; ∆ = 0.126). The incremental cost-effectiveness ratio was €8039/QALY, which is well below the willingness-to-pay threshold of €30 000/QALY in Italy. The results showed that CAZ-AVI is expected to be a cost-effective treatment compared with imipenem for cUTI in Italy
First microlensing candidate towards M31 from the Nainital Microlensing Survey
We report our first microlensing candidate NMS-E1 towards M31 from the data
accumulated during the four years of Nainital Microlensing Survey. Cousin R and
I band observations of ~13'x13' field in the direction of M31 have been carried
out since 1998 and data is analysed using the pixel technique proposed by the
AGAPE collaboration. NMS-E1 lies in the disk of M31 at \alpha = 0:43:33.3 and
\delta = +41:06:44, about 15.5 arcmin to the South-East direction of the center
of M31. The degenerate Paczy\'{n}ski fit gives a half intensity duration of ~59
days. The photometric analysis of the candidate shows that it reached R~20.1
mag at the time of maximum brightness and the colour of the source star was
estimated to be (R-I)_0 ~ 1.1 mag. The microlensing candidate is blended by red
variable stars; consequently the light curves do not strictly follow the
characteristic Paczy\'{n}ski shape and achromatic nature. However its long
period monitoring and similar behaviour in R and I bands supports its
microlensing nature.Comment: no changes except typos corrected, to appear in A&
Glueballs, closed fluxtubes and eta(1440)
The component of the pseudoscalar has strong
affinity for glue. But its mass is incompatible with lattice simulations that
predict a much higher value for the glueball. As a consequence it has
been suggested that could signal physics beyond the Standard
Model. Here we argue that if glueballs are closed gluonic fluxtubes then
is a prime candidate for the glueball. Furthermore, in
the absence of parity violating terms its mass should be degenerate with that
of the glueball. We also suggest that the decay properties of such
glueballs could be employed as probes for extra dimensions.Comment: 11 page
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant <i>Staphylococcus aureus</i>
AbstractWe aimed to characterize real-world dosing of weight-based intravenous (IV) antibiotic therapy in patients hospitalized for methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft-tissue infections (cSSTIs). This was a subgroup analysis of a retrospective chart review that captured data from 12 European countries. The study included patients ≥18 years old, hospitalized with an MRSA cSSTI between 1 July 2010 and 30 June 2011 and discharged alive by 31 July 2011. Patients treated with IV vancomycin, teicoplanin or daptomycin at any stage during hospitalization were included in this analysis. Analyses were conducted at the regimen level (dosing in mg/kg or in mg, frequency, and total daily dose (TDD)), with potentially multiple regimens per patient, and the patient level, categorizing patients into low, standard (labelled) and high dosing groups according to their initial MRSA-targeted regimen. Among the 1502 patients in the parent study, 998 patients contributed a total of 1050 daptomycin, teicoplanin or vancomycin regimens. Across all regimens, the mean initial TDDs were 6.3 ± 1.9 mg/kg for daptomycin, 10.5 ± 4.9 mg/kg for teicoplanin and 28.5 ± 11.5 mg/kg for vancomycin. A total of 789 patients received first-line therapy with one of the above antibiotics. The majority of patients receiving first-line teicoplanin and daptomycin (96% and 80%, respectively) received higher than labelled cSSTI doses, whereas vancomycin doses were lower than labelled doses in >40% of patients. These real-world data reveal significant deviation from labelled antibiotic dosing in 12 European countries and the potential for suboptimal outcomes in patients with MRSA cSSTIs
The CAT Imaging Telescope for Very-High-Energy Gamma-Ray Astronomy
The CAT (Cherenkov Array at Themis) imaging telescope, equipped with a
very-high-definition camera (546 fast phototubes with 0.12 degrees spacing
surrounded by 54 larger tubes in two guard rings) started operation in Autumn
1996 on the site of the former solar plant Themis (France). Using the
atmospheric Cherenkov technique, it detects and identifies very high energy
gamma-rays in the range 250 GeV to a few tens of TeV. The instrument, which has
detected three sources (Crab nebula, Mrk 421 and Mrk 501), is described in
detail.Comment: 24 pages, 15 figures. submitted to Elsevier Preprin
- …